China's first fully independent intellectual property rights molecular imaging medical apparatus

Detection technology only international leading

A long touch domestic pharmaceutical researchers pain is that China did not have a completely independent intellectual property rights of high-end molecular imaging medical equipment, in molecular imaging this emerging field is blank.

It is understood that, at present, China's hospitals and research institutes for clinical and research of medical imaging equipment, particularly large medical imaging equipment essential dependence on imports.

In order to break through the restriction of life science research on key issues in the field of development, since 2003, Chinese Academy of Sciences, Institute of automation, Chinese Academy of Sciences Prof. Tian lead nearly 50 master's and doctoral team engaged in "medical imaging and molecular imaging research and development".

In 2006, the Ministry of science and technology key to approved "Molecular Imaging Science and technology research" into national 973 project by Prof. Tian as Chief Scientist.

To date, this project has made significant accomplishments.

Yet, results of molecular imaging system has achieved a result transformation. This December, Guangzhou Branch Kai Sheng medical equipment co., Ltd. use of existing research results-oriented market with in vivo molecular imaging system autofluorescence, filling the domestic wholly owns independent intellectual property rights of high-end medical equipment market.

According to the official responsible for the company, present on the international market has a similar product.

But, technically, zhongke Kai sheng of molecular imaging system to undertake a more comprehensive "complex non-homogeneous living detection", to distinguish the body, heart, liver, spleen, lungs and other organs. The technology has to meet or exceed the international advanced level, but its price is far below the current market has some similar products.

Born in the early detection of lesions of objects

In vivo molecular imaging system consists of visible light imaging system, processing stations, three part imaging software

Molecular imaging systems launched the prototype at the end of last year, after nearly a year, is now fully to marketing.

The official said, the system can be observed diseases, especially cancer disease occurrence, development process, as well as on the drug treatment, and can be used for the study of Virology, build transgenic animal model, stem cell research, study and protein-protein interaction in vitro testing, etc.

Most attract people attention is that the system to detect organisms without prejudice to the role.

It is understood that the present application of the general medical x-ray, CT and other technologies because the relationship between applied ray will have some side effects on the human body. Whereas the system of molecular imaging technology is the use of near infrared light to detect, test organisms without any damage and side effects.

In addition, compared to CT technology, molecular imaging system in the early detection of diseases lesions.

Such as cancer cells, the current technology can only after forming the lesion cell in order to detect, molecular imaging technology you can cells detect early lesions, really early diagnosis.

Molecular imaging systems for application areas include food safety, plant monitoring, drug prescriptions and dose management, zhongke Kai Sheng will focus on pushing products in drug development, clinical evaluation and testing.

In addition, the molecular imaging system in price has far exceeded the market similar products at home and abroad.

"Push the products do well is the most important responsibilities."

Economic development trends of a background is, 1-9, 2008, the province's high-tech products worth $ 1.7 trillion, the growth rate of up to 20%; high-tech exports 1105.72 trillion, an increase of 18.1%; patent 72125, patented authorized 45822 20326 applications for invention patents.

This shows that high-tech industry development momentum is very rapid.

In order to promote the development of high-tech industry, the Guangdong provincial party Committee and Government introduced 20 more policy files, this September in the Ministry of science and technology, the support of the Ministry of education, two a province together launched the Guangdong innovation planning outline ", the provincial government has introduced the innovative construction of Guangdong Province, Guangdong Province, the platform for action, and other files, and formed a strong policy support system.

Zhongke Kevin Shing company as Guangzhou focus on fostering high-tech enterprise, molecular imaging technology has become a major research project in Guangzhou, access to the Special Fund of 5 million.

The company believes that such a policy environment on high-tech enterprises, is very encouraging. Currently, zhongke Kai sheng also with Xidian University to set up a "Biomedical Imaging Center at the Ministry of education project", to continue the study of molecular imaging products.

Next, the company will build a high quality service platform, product promotion, to achieve social and economic benefits of the "bumper".